SI1720979T1 - Uporaba medija za celiäśno kulturo brez seruma zaizdelavo il-18bp pri celicah sesalcev - Google Patents

Uporaba medija za celiäśno kulturo brez seruma zaizdelavo il-18bp pri celicah sesalcev

Info

Publication number
SI1720979T1
SI1720979T1 SI200530084T SI200530084T SI1720979T1 SI 1720979 T1 SI1720979 T1 SI 1720979T1 SI 200530084 T SI200530084 T SI 200530084T SI 200530084 T SI200530084 T SI 200530084T SI 1720979 T1 SI1720979 T1 SI 1720979T1
Authority
SI
Slovenia
Prior art keywords
mammalian cells
serum
production
culture medium
cell culture
Prior art date
Application number
SI200530084T
Other languages
English (en)
Inventor
Yehoshua Aloni
Orit Aharonovitz
Thierry Ziegler
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of SI1720979T1 publication Critical patent/SI1720979T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0043—Medium free of human- or animal-derived components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/76—Undefined extracts from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/33—Insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
SI200530084T 2004-03-01 2005-02-28 Uporaba medija za celiäśno kulturo brez seruma zaizdelavo il-18bp pri celicah sesalcev SI1720979T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP04100800 2004-03-01
US55117104P 2004-03-08 2004-03-08
PCT/EP2005/050855 WO2005083058A1 (en) 2004-03-01 2005-02-28 Use of a serum-free cell culture medium for the production of il-18bp in mammalian cells
EP05729822A EP1720979B1 (en) 2004-03-01 2005-02-28 Use of a serum-free cell culture medium for the production of il-18bp in mammalian cells

Publications (1)

Publication Number Publication Date
SI1720979T1 true SI1720979T1 (sl) 2007-12-31

Family

ID=34928882

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200530084T SI1720979T1 (sl) 2004-03-01 2005-02-28 Uporaba medija za celiäśno kulturo brez seruma zaizdelavo il-18bp pri celicah sesalcev

Country Status (19)

Country Link
US (1) US7553665B2 (sl)
EP (1) EP1720979B1 (sl)
JP (1) JP4713567B2 (sl)
AT (1) ATE375385T1 (sl)
AU (1) AU2005217154B2 (sl)
CA (1) CA2554238C (sl)
CY (1) CY1107014T1 (sl)
DE (1) DE602005002829T2 (sl)
DK (1) DK1720979T3 (sl)
ES (1) ES2292127T3 (sl)
HR (1) HRP20070474T3 (sl)
IL (1) IL177493A (sl)
ME (1) ME01218B (sl)
NO (1) NO335825B1 (sl)
PL (1) PL1720979T3 (sl)
PT (1) PT1720979E (sl)
RS (1) RS50531B (sl)
SI (1) SI1720979T1 (sl)
WO (1) WO2005083058A1 (sl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101111103B1 (ko) * 2000-02-10 2012-02-13 아보트 러보러터리즈 사람 인터류킨-18에 결합하는 항체 및 이를 제조하고 사용하는 방법
SI1601776T1 (sl) 2003-03-11 2008-10-31 Serono Lab Ekspresijski vektorji, ki vsebujejo mcmv ie2 promotor
CA2524403C (en) * 2003-05-13 2013-07-09 Applied Research Systems Ars Holding N.V. Active variants of the il-18 binding protein and medical uses thereof
ES2354160T3 (es) * 2003-10-21 2011-03-10 Merck Serono Sa Secuencia de adn mínima que actúa como un aislante de cromatina, y su uso en la expresión de proteínas.
ATE360647T1 (de) * 2003-11-05 2007-05-15 Ares Trading Sa Verfahren zur aufreinigung von il-18-bindendem protein
US7968684B2 (en) 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
ATE408616T1 (de) * 2004-06-29 2008-10-15 Ares Trading Sa Verfahren zur aufreinigung von il-18-bindendem protein
AU2005322353B2 (en) * 2004-12-23 2011-09-01 Medimmune, Llc Non-tumorigenic MDCK cell line for propagating viruses
US7691611B2 (en) * 2005-06-03 2010-04-06 Ares Trading S.A. Production of recombinant IL-18 binding protein
JP5091127B2 (ja) * 2005-06-10 2012-12-05 アレス トレーディング ソシエテ アノニム Ｉｌ−１８結合タンパク質の精製のための方法
RU2487935C2 (ru) 2006-09-15 2013-07-20 Медиммун, Ллк. Линии клеток почки собаки майдин-дэрби (mdck), поддерживающие рост вирусов до высоких титров, и способ применения этих клеток в биореакторе
HUE037633T2 (hu) 2007-07-09 2018-09-28 Genentech Inc Diszulfidkötés redukciójának megelõzése polipeptidek rekombináns elõállítása során
EP2344634A4 (en) * 2008-09-24 2012-08-29 Medimmune Llc METHODS OF CELL CULTURE, AND PROPAGATION AND PURIFICATION OF VIRUSES
DE102008051574A1 (de) * 2008-10-14 2010-04-15 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren zur Herstellung von Interferon-beta und deren Varianten
SG10201901417UA (en) * 2009-08-11 2019-03-28 Genentech Inc Production of proteins in glutamine-free cell culture media
SG11201700023WA (en) * 2014-07-16 2017-02-27 Heartseed Inc New undifferentiated stem cell removal and myocardial purification and refinement culture medium
CN106676053B (zh) * 2016-12-31 2020-08-25 山东甲骨文生物科技有限公司 一种具有广泛适应性的低血清细胞培养基及其制备方法
CN107574150A (zh) * 2017-09-06 2018-01-12 万向东方生物科技有限公司 一种无血清免疫细胞培养基及其制备方法
CN108102982B (zh) * 2018-02-07 2021-06-01 山东出入境检验检疫局检验检疫技术中心 麦氏弧菌的真空冷冻干燥保护剂及其保藏方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0249579A (ja) * 1988-02-29 1990-02-19 Kyowa Hakko Kogyo Co Ltd 培地
JP3649249B2 (ja) 1995-02-23 2005-05-18 クエスト・インターナショナル・サービシーズ・ビー・ブイ 組織および細胞培養用ペプチド
DE69738806D1 (de) * 1996-10-10 2008-08-14 Invitrogen Corp Tierzellkulturmedium mit pflanzlichen nährstoffen
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use
US6406909B1 (en) * 1998-07-10 2002-06-18 Chugai Seiyaku Kabushiki Kaisha Serum-free medium for culturing animal cells
AT409379B (de) * 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
UA74557C2 (en) 1999-09-03 2006-01-16 Applied Research Systems A method for producing a heterologous secreted protein from chinese hamster ovaries cells grown on microcarriers
US20030096414A1 (en) * 2001-03-27 2003-05-22 Invitrogen Corporation Culture medium for cell growth and transfection
EP1520008B1 (en) * 2002-07-09 2012-09-05 Baxter International Inc. Animal protein free media for cultivation of cells
SI1601776T1 (sl) * 2003-03-11 2008-10-31 Serono Lab Ekspresijski vektorji, ki vsebujejo mcmv ie2 promotor
CA2524403C (en) 2003-05-13 2013-07-09 Applied Research Systems Ars Holding N.V. Active variants of the il-18 binding protein and medical uses thereof
ES2354160T3 (es) * 2003-10-21 2011-03-10 Merck Serono Sa Secuencia de adn mínima que actúa como un aislante de cromatina, y su uso en la expresión de proteínas.
ATE360647T1 (de) 2003-11-05 2007-05-15 Ares Trading Sa Verfahren zur aufreinigung von il-18-bindendem protein
ATE408616T1 (de) * 2004-06-29 2008-10-15 Ares Trading Sa Verfahren zur aufreinigung von il-18-bindendem protein
US7691611B2 (en) 2005-06-03 2010-04-06 Ares Trading S.A. Production of recombinant IL-18 binding protein
JP5091127B2 (ja) 2005-06-10 2012-12-05 アレス トレーディング ソシエテ アノニム Ｉｌ−１８結合タンパク質の精製のための方法

Also Published As

Publication number Publication date
WO2005083058A1 (en) 2005-09-09
AU2005217154A1 (en) 2005-09-09
ES2292127T3 (es) 2008-03-01
HRP20070474T3 (en) 2007-11-30
CA2554238C (en) 2013-02-12
NO335825B1 (no) 2015-02-23
US20070196895A1 (en) 2007-08-23
US7553665B2 (en) 2009-06-30
ME01218B (me) 2013-06-20
ATE375385T1 (de) 2007-10-15
EP1720979A1 (en) 2006-11-15
JP2007525228A (ja) 2007-09-06
DK1720979T3 (da) 2007-12-10
RS50531B (sr) 2010-05-07
IL177493A (en) 2010-12-30
JP4713567B2 (ja) 2011-06-29
EP1720979B1 (en) 2007-10-10
IL177493A0 (en) 2006-12-10
DE602005002829D1 (de) 2007-11-22
PT1720979E (pt) 2007-10-25
CY1107014T1 (el) 2012-09-26
DE602005002829T2 (de) 2008-07-10
PL1720979T3 (pl) 2008-03-31
NO20064379L (no) 2006-10-19
AU2005217154B2 (en) 2010-02-18
CA2554238A1 (en) 2005-09-09

Similar Documents

Publication Publication Date Title
HRP20070474T3 (en) Use of a serum-free cell culture medium for the production of il-18bp in mammalian cells
NZ598677A (en) Production of proteins in glutamine-free cell culture media
AU2019268194A1 (en) Cell culture system
NO20072719L (no) Serumfritt cellekulturmedium for pattedyrceller
MX2010002426A (es) Agente para promover la adhesion de las celulas del endotelio corneal.
MX2009011805A (es) Mejora de las concentraciones de polipeptido del factor viii en cultivos celulares.
EP4364797A3 (en) Cardiomyocyte production
WO2007016485A3 (en) Use of a gsk-3 inhibitor to maintain potency of cultured cells
GB2441488A (en) Suspension culture of human embryonic stem cells
EP2896690A3 (en) Use of RNA for reprogramming somatic cells
WO2010096588A3 (en) Cell culture media containing combinations of proteins
GB2441718A (en) Differentiation of primate pluripotent stem cells to cardiomyocyte-lineage cells
SG170021A1 (en) Compositions and methods useful for culturing differentiable cells
NZ586250A (en) Cell culture processes
NZ591812A (en) Cell culture method to form aggregates
WO2008153180A1 (ja) 脂肪組織由来細胞から肝小葉様細胞塊を得る方法
WO2007016366A3 (en) Defined culture conditions of human embryonic stem cells
GB2477698A (en) Methods for conducting cellular assays
WO2006004728A3 (en) Cell culture medium comprising transition metals or trace elements
MX2009007114A (es) Produccion de enzima en un medio de cultivo que comprende glicerol crudo.
GB2453074A (en) Differentiation of primate pluripotent cells to hepatocyte-lineage cells
WO2009152417A3 (en) Methods for improving viability and productivity in cell culture
NZ597728A (en) Method for obtaining myofibroblasts
MX2021012696A (es) Metodo de metanizacion en un biorreactor en condiciones de retencion celular continua.
WO2007056062A3 (en) Methods for adapting mammalian cells